In January 2013, Grégoire Prévost created his own company CIPREVO based in France. CIPREVO is an expertise provider supporting all the strategic and scientific aspects of the research and development in Oncology.

Grégoire brings 30 years of experience in Oncology research and development. He obtained his PhD in Molecular and Cellular Biology in 1989 at the Institut Pasteur of Paris/ University of Tours (France), and continued his scientific career as a post-doctorate at IOCMH (Bobigny, France) and BIOMEASURE (Milford, MA, USA).

In 1995, he was appointed as Oncology research leader at Beaufour-IPSEN (Les Ulis, France) and held progressive positions at IPSEN, among which Oncology Translational Research Director, Oncology Scientific Affairs Director and member of the Oncology Portfolio Management Team. In March 2011, Grégoire joined a start-up company InteRNA Technologies (Utrecht, The Netherlands) as Chief Development Officer.

He has participated to the transfer of 3 drug candidates to the clinic and has been a significant contributor to Oncology field with more than 100 scientific publications and patent families. In addition in 2012, he co-founded the Sino-French School of Oncology in Wuhan with Professor Jianfeng Liu from HUST, Wuhan.